Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03369717 · ClinicalTrials.gov registry record · Phase 4

Use of Perioperative Antibiotics in Endoscopic Sinus Surgery

A Phase 4 study, sponsored by Montefiore Medical Center.

Terminated
Registry status
Phase 4
Development phase
24
Enrollment target

NCT03369717 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03369717, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.

TERMINATED
Registry status
Phase 4
Development phase
24 participants
Enrollment target

Study Summary

The objective of this study is to determine whether the use of postoperative antibiotics following endoscopic sinus surgery (ESS) decreases postoperative infection rates. This is a multi-institutional prospective study involving Albert Einstein College of Medicine/Montefiore Medical Center, Columbia University Medical Center, Weill Cornell Medical College, Mount Sinai Health System, and New York University Langone Medical Center. The study design will be a multi-institutional prospective randomized controlled trial with parallel random groups assigned to receive postoperative antibiotics or no postoperative antibiotics. The investigators hypothesize that patients who receive postoperative antibiotics will have lower postoperative infection rates and improved postoperative sinonasal symptoms and nasal endoscopy scores.

Interventions

  • DRUG Amoxi Clavulanate

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-08-01
Est. Completion 2020-05-07
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT03369717

The ClinicalTrials.gov registry entry for NCT03369717 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Amoxi Clavulanate is the first listed.

NCT03369717 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03369717 about?

NCT03369717 is a clinical study titled "Use of Perioperative Antibiotics in Endoscopic Sinus Surgery". The objective of this study is to determine whether the use of postoperative antibiotics following endoscopic sinus surgery (ESS) decreases postoperative infection rates. This is a multi-institutional prospective study involving Albert Einstein College of Medicine/Montefiore Medical Center, Columbia...

What is the current status of trial NCT03369717?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2018-08-01. Estimated completion is 2020-05-07.

What interventions are being tested in trial NCT03369717?

The interventions under investigation include: Amoxi Clavulanate (DRUG).

Who is sponsoring clinical trial NCT03369717?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.